In the longer term, Q-Stim may
also provide therapeutic neurostimulation for Alzheimer’s
disease, anxiety, bulimia, obsessive-compulsive disorder,
Tourette’s syndrome, and other ailments. As Dr.
Ali R. Rezai, director of functional neurosurgery at
the Cleveland Clinic, has said of neurostimulation in
general: “Any organ that a nerve can influence
– and that’s every organ in the body –
can be affected using this technology.”
Virginia Technologies has developed reference designs
and a prototype Q-Stim neurostimulator, with an eye
toward treating these and other indications. The company
would be happy to review these with developers who wish
to license Q-Stim technology for their own therapeutic
devices. To explore this opportunity, please
click
here.
back to top >